Xermelo 250 mg, Filmtabletten

7680663740012 CH-66374 Filmtabletten
Xermelo 250 mg, Filmtabletten
Xermelo 250 mg, Filmtabletten
Xermelo 250 mg, Filmtabletten
1 / 3
google

Article details

Package size
90
Selling units
90
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/04/2023
Patient information leaflet
Français
11/04/2023
Patient information leaflet
Italien
11/04/2023
Summary of Product Characteristics
Allemand
11/04/2023
Summary of Product Characteristics
Français
11/04/2023
Summary of Product Characteristics
Italien
11/04/2023

Detailed composition

Substance Quantity Type Category
ethylis telotristatas
250.0 MG Substance Wirkstoff (Principe actif)
telotristati etipras
327.9 MG Substance WIZUS
telotristatum
237.8 MG Substance WIZUS
lactosum
167.91 MG Substance HBESI
hydroxypropylcellulosum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
natrium
4.54 MG Substance HBESI
magnesii stearas
- Substance HNIDK
silica colloidalis
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
macrogolum 3350
- Substance HNIDK
talcum
- Substance HNIDK
E 171
- Substance FNIDK

Authorization holder

Future Health Pharma GmbH

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
66374
Drug name
Xermelo, Filmtabletten
Galenic form
FILM
ATC Code
A16AX15
Authorization status
Z
Dispensing category
B
First authorization
28/03/2018
Authorization expiration date
31/12/9999
IT Number
07.16.4.
Domain
Human medicine
Field of application
Karzinoid-Syndrom-bedingte Diarrhö

Package details

Description (FR)
XERMELO cpr pell 250 mg 90 pce
Description (DE)
XERMELO Filmtabl 250 mg 90 Stk
Market launch
28/03/2018
Narcotic (BTM)
No
Buy us a coffee Explore the data